New study measures nerve loss in SMA adults without offering treatment
NCT ID NCT04139343
First seen Feb 23, 2026 · Last updated May 12, 2026 · Updated 9 times
Summary
This study looked at 67 adults with spinal muscular atrophy (SMA) types 2 and 3 to see how well special electrical tests (MUNE and CMAP) can measure nerve damage over time. Participants did not receive any treatment; the goal was simply to learn if these tests are good at tracking disease severity and progression. The findings may help doctors better monitor SMA in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University Medical Center
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.